Latest News

brain colorful | Image credit: vegefox -
EC Approves First MS Biosimilar; Coherus Receives CRL for Neulasta Onpro Competitor

September 27th 2023

With the European Commission's (EC) approval of Tyruko, Europe receives its first natalizumab biosimilar and first biosimilar to treat multiple sclerosis (MS), while Coherus Biosciences received a complete response letter (CRL) for its biosimilar for Neulasta Onpro.

globe and an atom
Regulatory Updates From Around the Globe Provide Hope for Biosimilars

September 9th 2023

brain and spine | Image credit: freshidea -
FDA Approves First MS Biosimilar

August 25th 2023

eye on pharma banner
Eye on Pharma: First PBM to Cover Yusimry; Celltrion to Test Ocrevus Biosimilar; Another Stelara Settlement

June 15th 2023

remsima sc
Celltrion Launches Biobetter in Brazil, Shares Phase 3 Plan for MS Biosimilar

May 22nd 2023

Video Interviews

More News

© 2023 MJH Life Sciences

All rights reserved.